IDH1 and glioma: We assessed the SWI signals of patients with gliomas to determine ITSS and pathological grades as well as expression levels of molecular markers, to assess correlations between ITSS grades and pathological grades, IDH1 mutation status, MGMT promoter methylation status, and 1p19q deletion status.